Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America
- PMID: 15577752
Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America
Erratum in
- MMWR Morb Mortal Wkly Rep. 2006 Aug 4;55(30):824. Dosage error in article text
Abstract
In 2001, CDC, the National Institutes of Health, and the Infectious Diseases Society of America convened a working group to develop guidelines for therapy of human immunodeficiency virus (HIV)-associated opportunistic infections to serve as a companion to the Guidelines for Prevention of Opportunistic Infections Among HIV-Infected Persons. In recognition of unique considerations related to HIV infection among infants, children, and adolescents, a separate pediatric working group was established. Because HIV-infected women coinfected with opportunistic pathogens might be more likely to transmit these infections to their infants than women without HIV infection, guidelines for treating opportunistic pathogens among children should consider treatment of congentially acquired infections among both HIV-exposed but uninfected children and those with HIV infection. In addition, the natural history of opportunistic infections among HIV-infected children might differ from that among adults. Compared with opportunistic infections among HIV-infected adults, which are often caused by reactivation of pathogens acquired before HIV infection when host immunity was intact, opportunistic infections among children often reflect primary acquisition of the pathogen and, among children with perinatal HIV infection, infection acquired after HIV infection has been established and begun to compromise an already immature immune system. Laboratory diagnosis of opportunistic infections can be more difficult with children. Finally, treatment recommendations should consider differences between adults and children in terms of drug pharmacokinetics, dosing, formulations, administration, and toxicities. This report focuses on treatment of opportunistic infections that are common in HIV-exposed and infected infants, children, and adolescents in the United States.
Similar articles
-
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166. MMWR Recomm Rep. 2009. PMID: 19730409 Free PMC article.
-
Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.Clin Infect Dis. 2005 Feb 1;40 Suppl 1:S1-84. doi: 10.1086/427295. Clin Infect Dis. 2005. PMID: 15655768
-
Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.MMWR Recomm Rep. 2002 Jun 14;51(RR-8):1-52. MMWR Recomm Rep. 2002. PMID: 12081007
-
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).Infect Dis Obstet Gynecol. 2000;8(1):5-74. doi: 10.1155/S1064744900000028. Infect Dis Obstet Gynecol. 2000. PMID: 10741830 Free PMC article. Review. No abstract available.
-
Pulmonary infections in children with HIV infection.Semin Respir Infect. 2002 Mar;17(1):33-46. doi: 10.1053/srin.2002.31685. Semin Respir Infect. 2002. PMID: 11891517 Review.
Cited by
-
Toxic epidermal necrolysis caused by fluconazole in a patient with human immunodeficiency virus infection.J Pharmacol Pharmacother. 2012 Jul;3(3):276-8. doi: 10.4103/0976-500X.99445. J Pharmacol Pharmacother. 2012. PMID: 23129968 Free PMC article.
-
Diarrhea in patients with AIDS.Curr Treat Options Gastroenterol. 2006 Feb;9(1):23-37. doi: 10.1007/s11938-006-0021-8. Curr Treat Options Gastroenterol. 2006. PMID: 16423311
-
Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy.Paediatr Drugs. 2007;9(5):301-9. doi: 10.2165/00148581-200709050-00003. Paediatr Drugs. 2007. PMID: 17927302
-
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166. MMWR Recomm Rep. 2009. PMID: 19730409 Free PMC article.
-
Unusual orofacial manifestations of histoplasmosis in renal transplanted patient.Mycopathologia. 2006 Mar;161(3):161-5. doi: 10.1007/s11046-005-0195-y. Mycopathologia. 2006. PMID: 16482388
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical